Sigmapharm Laboratories, LLC, develops and manufactures unique generic and branded products. Backed by our proprietary technologies and state-of-the-art Research & Development, Analytical Chemistry and Manufacturing facilities, Sigmapharm's potential for success is virtually unlimited!

Commercial Product Catalog   See Our Approved Products List



Flucytosine Capsules, USP
Compare to Ancobon®*

Flucytosine Capsules are indicated only in the treatment of serious infections caused by susceptible strains of Candida and/or Cryptococcus.

Liothyronine Sodium Tablets, USP
Compare to Cytomel®*

Liothyronine Sodium Tablets, USP are a thyroid hormone drug indicated:

  • As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis.
  • As pituitary thyroid-stimulating hormone (TSH) suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic lymphocytic thyroiditis (Hashimoto’s) and multinodular goiter.
  • As diagnostic agents in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy.

Sodium Phenylbutyrate Powder
Compare to Buphenyl®*

Sodium Phenylbutyrate Powder is indicated as adjunctive therapy in the chronic management of patients with urea cycle disorders involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS).

* Disclaimer: All images shown are for illustrative purposes only. Actual product may vary due to image enhancement. The images and information for a particular product may change over time. For the most up-to-date product information, please contact Sigmapharm Laboratories, LLC.